Intervention Review

Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease

  1. Katherine Deane2,
  2. Sybille Spieker3,
  3. Carl E Clarke1,*

Editorial Group: Cochrane Movement Disorders Group

Published Online: 18 OCT 2004

Assessed as up-to-date: 7 JUN 2004

DOI: 10.1002/14651858.CD004553.pub2

How to Cite

Deane K, Spieker S, Clarke CE. Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD004553. DOI: 10.1002/14651858.CD004553.pub2.

Author Information

  1. 1

    City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Department of Neurology, Birmingham, West Midlands, UK

  2. 2

    Newcastle University, Institute of Health & Society, Newcastle-upon-Tyne, UK

  3. 3

    Marburg, Germany

*Carl E Clarke, Department of Neurology, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Dudley Road, Birmingham, West Midlands, B18 7QH, UK. c.e.clarke@bham.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 OCT 2004

SEARCH